Human blood-derived fibrin releasates: Composition and use for the culture of cell lines and human primary cells

van der Valk, 2010, Optimization of chemically defined cell culture media–replacing fetal bovine serum in mammalian in vitro methods, Toxicol In Vitro, 24, 1053, 10.1016/j.tiv.2010.03.016

WHO. WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies. http://www.who.int/bloodproducts2006.

Bieback, 2009, Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow, Stem Cells, 27, 2331, 10.1002/stem.139

van der Valk, 2004, The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In, Vitro, 18, 1, 10.1016/j.tiv.2003.08.009

Gstraunthaler, 2003, Alternatives to the use of fetal bovine serum: serum-free cell culture, Altex Altern Tierexp, 20, 275

Burnouf, 2011, Recombinant plasma proteins, Vox Sang, 100, 68, 10.1111/j.1423-0410.2010.01384.x

Grillberger, 2009, Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells, Biotechnol J, 4, 186, 10.1002/biot.200800241

Alden, 2007, Porcine platelet lysate as a supplement for animal cell culture, Cytotechnology, 55, 3, 10.1007/s10616-007-9097-9

Schallmoser, 2007, Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells, Transfusion, 47, 1436, 10.1111/j.1537-2995.2007.01220.x

Doucet, 2005, Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications, J Cell Physiol, 205, 228, 10.1002/jcp.20391

Bernardo, 2007, Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute, J Cell Physiol, 211, 121, 10.1002/jcp.20911

Riem Vis, 2010, Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering, Tissue Eng Part A, 16, 1317, 10.1089/ten.tea.2009.0331

Burnouf, 2009, Blood-derived biomaterials: fibrin sealant, platelet gel and platelet fibrin glue, ISBT Sci Ser, 4, 136, 10.1111/j.1751-2824.2009.01222.x

Anitua, 2004, Autologous platelets as a source of proteins for healing and tissue regeneration, Thromb Haemost, 91, 4, 10.1160/TH03-07-0440

Barrientos, 2008, Growth factors and cytokines in wound healing, Wound Repair Regen, 16, 585, 10.1111/j.1524-475X.2008.00410.x

Mazzucco, 2010, Platelet-derived factors involved in tissue repair-from signal to function, Transfus Med Rev, 24, 218, 10.1016/j.tmrv.2010.03.004

Borzini, 2005, Platelet gels and releasates, Curr Opin Hematol, 12, 473, 10.1097/01.moh.0000177831.70657.e8

Dohan, 2006, Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, e37, 10.1016/j.tripleo.2005.07.008

Su, 2009, In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, 56, 10.1016/j.tripleo.2009.02.004

Burnouf, 2008, Solvent/detergent treatment of platelet concentrates enhances the release of growth factors, Transfusion, 48, 1090, 10.1111/j.1537-2995.2008.01691.x

Su, 2009, A virally inactivated functional growth factor preparation from human platelet concentrates, Vox Sang, 97, 119, 10.1111/j.1423-0410.2009.01180.x

Mannello, 2007, Stem Cells, 25, 1603, 10.1634/stemcells.2007-0127

Genzel, 2006, Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture, Vaccine, 24, 3261, 10.1016/j.vaccine.2006.01.019

Batista, 2009, Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium, Biologicals, 37, 108, 10.1016/j.biologicals.2008.11.001

Barnes, 1980, Methods for growth of cultured cells in serum-free medium, Anal Biochem, 102, 255, 10.1016/0003-2697(80)90151-7

Lubiniecki, 1999, Elimination of serum from cell culture medium, Dev Biol Stand, 99, 153

Wu, 2003, Preventing HIV/AIDS with candidate vaccines: addition of inactivated primary isolates expanded in CD4-enriched cell substrate, Indian J Hematol Blood Transfus, 21, 69

Lai-Hipp, 2011, Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection, Transfusion, 51, 333, 10.1111/j.1537-2995.2010.02831.x

Balk, 1981, Mitogenic factors present in serum but not in plasma, Proc Natl Acad Sci U S A, 78, 5656, 10.1073/pnas.78.9.5656

Clemmons, 2006, Clinical utility of measurements of insulin-like growth factor 1, Nat Clin Pract Endocrinol Metab, 2, 436, 10.1038/ncpendmet0244

Hsu, 2009, The negative effect of platelet-rich plasma on the growth of human cells is associated with secreted thrombospondin-1, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, 185, 10.1016/j.tripleo.2008.07.016

Pillitteri, 2007, Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes, Platelets, 18, 119, 10.1080/09537100600800792

Horn, 2010, Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells, Cytotherapy, 12, 888, 10.3109/14653249.2010.501788

von Bonin, 2009, Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium, Bone Marrow Transplant, 43, 245, 10.1038/bmt.2008.316

Kocaoemer, 2007, Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue, Stem Cells, 25, 1270, 10.1634/stemcells.2006-0627

Schallmoser, 2009, Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures, J Vis Exp

de Korte, 2001, Determination of the degree of bacterial contamination of whole-blood collections using an automated microbe-detection system, Transfusion, 41, 815, 10.1046/j.1537-2995.2001.41060815.x

Blajchman, 2005, Bacterial detection of platelets: current problems and possible resolutions, Transfus Med Rev, 19, 259, 10.1016/j.tmrv.2005.05.002

Burnouf, 2000, Reducing the risk of infection from plasma products: specific preventative strategies, Blood Rev, 14, 94, 10.1054/blre.2000.0129

Epstein, 2010, Alternative strategies in assuring blood safety: an overview, Biologicals, 38, 31, 10.1016/j.biologicals.2009.10.009

Klein, 2010, How safe is blood, really?, Biologicals, 38, 100, 10.1016/j.biologicals.2009.10.008

Busch, 2006, Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis, Transfusion, 46, 1624, 10.1111/j.1537-2995.2006.00957.x

Burnouf, 2006, Current strategies to prevent transmission of prions by human plasma derivatives, Transfus Clin Biol, 13, 320, 10.1016/j.tracli.2006.11.001

Shih, 2011, Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate, Transfusion, 51, 770, 10.1111/j.1537-2995.2010.02915.x

Marcus-Sekura, 2011, Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products, Biologicals, 40, 359, 10.1016/j.biologicals.2011.08.003